SOX18 and pulmonary arterial hypertension: Subsequent in vitro validation demonstrated that knockdown of the candidate genes resulted in a significant increase in the expression of SOX18.<h4>Conclusions</h4>Our novel platform, PAH-former, provides a powerful and broadly applicable strategy for disease-related gene discovery.